Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 58Leukemia 56Leukemia, Myeloid, Acute 47Lymphoma 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Lymphoma, Non-Hodgkin 35Leukemia, Lymphocytic, Chronic, B-Cell 35Myeloproliferative Disorders 34Multiple Myeloma 31Hodgkin Disease 30Leukemia, Myeloid, Chronic-Phase 28Leukemia, Myeloid, Accelerated Phase 28Lymphoma, Follicular 27Lymphoma, B-Cell, Marginal Zone 27Burkitt Lymphoma 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Mantle-Cell 25Neoplasms, Plasma Cell 24Leukemia, Myelomonocytic, Chronic 23Congenital Abnormalities 23Lymphoma, Large-Cell, Immunoblastic 22Myelodysplastic-Myeloproliferative Diseases 20Graft vs Host Disease 20Blast Crisis 20Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Anemia, Refractory, with Excess of Blasts 19Primary Myelofibrosis 18Dendritic Cell Sarcoma, Interdigitating 18Recurrence 17Hematologic Neoplasms 16

Interventions

Filgrastim 9Ifosfamide 8Etoposide 8Doxorubicin 8Cyclophosphamide 8Vincristine 7X-Rays 6Radiotherapy 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Topotecan 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Irinotecan 4Biopsy 4Thiotepa 3Imatinib Mesylate 3Carboplatin 3Bevacizumab 3ulixertinib 2tipifarnib 2temsirolimus 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neuroectodermal Tumors, Primitive, Peripheral × Antilymphocyte Serum × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT00084695 2014-01-10

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
CNSClassical hematologyLymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Recurrence, Sarcoma, Leukemia, Myeloid, Chronic-Phase, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡